secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vir Biotechnology, Inc. (VIR)
CIK:        0001706431
Form:       8-K
Filed at:   2024-05-29T23:59:59+00:00
Accession:  0001193125-24-149139
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Vir Biotechnology shareholders elect Class II directors, approve advisory compensation, ratify EY
--------------------------------------------------------------------------------

- Directors De Backer, Bischofberger, Farid, Nelsen elected with votes for/withheld: 105.6M/1.1M, 80.0M/26.7M, 106.4M/0.3M, 67.9M/38.8M; broker non-votes 12.3M.
- Advisory vote on executive compensation approved: 83.9M for, 22.6M against, 0.2M abstain; broker non-votes 12.3M.
- Ratification of Ernst & Young as auditor: 118.1M for, 679,046 against, 168,971 abstain; no broker non-votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1706431/000119312524149139/0001193125-24-149139-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1706431/000119312524149139/d771470d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-149139

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer